InnoPharma Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Piscataway NJ United States (2005)
Status: Acquired by Pfizer (2014)

Organization Overview

First Clinical Trial
2007
NCT01253837
First Marketed Drug
2018
bendamustine (treanda)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

INNOPHARMA | InnoPharma Inc. | INNOPHARMA LICENSING | INNOPHAR MO s.R.L.

Active Ingredients

Marketed Drugs (3)

bendamustine (treanda) (2018)

bromfenac (xibrom) (2019)

propofol (diprivan) (2020)

Drugs in Phase 3 Trials (1)

brinzolamide (azopt) (1 trial)

Drugs in Phase 2 Trials (1)

l19tnf (1 trial)

Drugs in Phase 1 Trials (1)

nox-e36 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 2)

Ocular Hypertension (Phase 3)

Renal Insufficiency (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3